AlphaE Expression in Inflammatory Bowel Disease: a Biomarker for the use of Etrolizumab?

Roosenboom, B; van Lochem, EG; Horje, CSHT

Roosenboom, B (reprint author), Rijnstate Hosp, Dept Gastroenterol & Hepatol, Wagnerlaan 55, NL-6815 AD Arnhem, Netherlands.

JOURNAL OF CROHNS & COLITIS, 2019; 13 (5): 671